Importantly, these tumors also underwent RNA-Seq, enabling us to examine PROX1 expression in specific prostate cancer subtypes defined by the Labrecque lineage plasticity subtype classifier (8). This evidence concerns the gene PROX1 and Familial prostate cancer.